Lung cancer drug safety check: 500 patients monitored
NCT ID NCT05100069
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 28 times
Summary
This study tracks side effects, especially lung-related ones, in 500 Japanese adults with a specific type of non-small cell lung cancer. Participants take Brigatinib tablets as part of their normal care, and doctors record any health issues for one year. The goal is to better understand the drug's safety in everyday use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda Selected Site
RECRUITINGTokyo, Japan
Conditions
Explore the condition pages connected to this study.